DUBLIN--(BUSINESS WIRE)--The "United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report has been added to ResearchAndMarkets.com's offering.
The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.
United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase.
Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells.
Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.
Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.
Key Topics Covered:
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market (Actual & Potential) - United States Proton Therapy Market (2009 - 2025)
4.1 Actual Proton Therapy Market
4.2 Potential Proton Therapy Market
5. Number of Patients - United States Proton Therapy (2009 - 2025)
5.1 Actual Numbers
5.2 Potential Numbers
6. Cancer Types - Patients Number in United States Proton Therapy (2009 - 2025)
6.1 Central Nervous System Tumors
6.2 Intraocular Melanomas Cancer
6.3 Pituitary Neoplasms Cancer
6.4 Base of Skull / Axial Skeleton Cancer
6.5 Head and Neck Cancer
6.6 Lung Cancer
6.7 Retroperitoneal Sarcoma Cancer
6.8 Pediatric Cancer Cases (Up to Age 18)
6.9 Gastrointestinal Tract Cancer
6.10 Urinary Tract Cancer
6.11 By Female Pelvic Organs Cancer
6.12 Prostate Cancer
6.13 Breast Cancer
6.14 Other Cancer
7. Cancer Types - United States Proton Therapy Market (2009 - 2025)
7.1 Central Nervous System Tumors
7.2 Intraocular Melanomas Cancer
7.3 Pituitary Neoplasms Cancer
7.4 Base of Skull / Axial Skeleton Cancer
7.5 Head and Neck Cancer
7.6 Lung Cancer
7.7 Retroperitoneal Sarcoma Cancer
7.8 Pediatric Cancer (Up to Age 18)
7.9 Gastrointestinal Tract Cancer
7.10 Urinary Tract Cancer
7.11 Female Pelvic Organs Cancer
7.12 Prostate Cancer
7.13 Breast Cancer
7.14 Other Cancer
8. United States - List of Proton Therapy Centers
8.1 Operating Proton Therapy Centers
8.2 Under-Construction Therapy Centers
8.3 Planning Proton Therapy Centers
9. By Centers - Number of Proton Therapy Patients Treated
9.1 Loma Linda (LLUMC) Proton Therapy Center (2008 - 2016)
9.2 UCSF - CNL Proton Therapy Center (2008 - 2015)
9.3 Boston (NPTC) Proton Therapy Center (2008 - 2016)
9.4 Bloomington (MPRI, 2) Proton Therapy Center (2008 - 2014)
9.5 Houston (MD Anderson) Proton Therapy Center (2008 - 2016)
9.6 UFPTI Jacksonville Proton Therapy Center (2008 - 2016)
9.7 Oklahoma City (ProCure PTC) Proton Therapy Center (2009 - 2017)
9.8 CDH Warrenville Proton Therapy Center (2010 - 2016)
9.9 Philadelphia (Upenn) Proton Therapy Center (2011 - 2016)
9.10 Hampton (HUPTI) Proton Therapy Center (2012 - 2016)
9.11 New Jersey (ProCure PTC) Proton Therapy Center (2012 - 2016)
9.12 Seattle (SCCA ProCure PTC) Proton Therapy Center (2013 - 2016)
9.13 St. Louis (S. Lee King PTC) Proton Therapy Center (2013 - 2016)
9.14 Provision Center for Proton Therapy, Knoxville, TN (2014 - 2016)
9.15 San Diego (Scripps PTC) (2014 - 2017)
9.16 Shreveport (Willis Knighton) Proton Therapy Center (2014 - 2017)
9.17 Jacksonville (Ackerman CC) Proton Therapy Center (2015 - 2016)
9.18 Rochester (Mayo PBTC) Proton Therapy Center (2015 - 2016)
9.19 Brunswick (Laurie PC) Proton Therapy Center (2015)
9.20 Irving (Texas Center for PT) Proton Therapy Center (2015 - 2017)
9.21 Memphis (St. Jude PTC) Proton Therapy Center (2015 - 2017)
9.22 Phoenix (Mayo PBTC) Proton Therapy Center (2016)
9.23 Baltimore (Maryland PTC) Proton Therapy Center (2016)
9.24 Cincinnati (Children's PTC) Proton Therapy Center (2016)
9.25 Orlando (Orlando Health PTC) Proton Therapy Center (2016)
9.26 Cleveland (UH Sideman PTC) Proton Therapy Center (2016)
10. Proton Therapy - Reimbursement Policies
10.1 Proton Therapy Reimbursement Policies for Patients
10.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
11. Components of a Standard Proton Therapy Center
11.1 Proton Accelerator
11.1.1 Synchrotrons (example: LLUMC at Loma Linda)
11.1.2 Cyclotrons (example: MGH Boston)
11.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
11.1.4 Linacs (Rome)
11.1.5 H-minus Synchrotrons
11.1.6 Separated Sector Cyclotrons
11.1.7 Super-conducting Cyclotrons
11.1.8 Fast Cycling Synchrotron
11.2 Beam Transport System
11.3 Beam Delivery System
11.3.1 The Passive Scattering Technique
11.3.2 Beam Scanning
11.4 Nozzle
11.4.1 Single Scattering
11.4.2 Double Scattering
11.4.3 Uniform Scanning Nozzle
11.4.4 Pencil Scanning Nozzle
11.5 Treatment Planning System
11.6 Image Viewers
11.7 Patient Positioning System (PPS)
11.8 Human Resource
12. Company Analysis (2014 - 2025)
12.1 IBA Proton Therapy
12.1.1 Sales Analysis
12.2 Varian Medical Systems
10.2.2 Sales Analysis
12.3 Elekta
12.3.1 Sales Analysis
13. Driving Factors
13.1 Technology Advancement
13.1.1 Next-Generation Proton Technique
13.2 Growing Incidence of Cancer Patients in United States
14. Challenges
14.1 Requires Huge Investment
14.2 Operations Challenges
For more information about this report visit https://www.researchandmarkets.com/r/65ph3p
